We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

48 hedge funds and large institutions have $67M invested in VIVEVE MED INC in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 7

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

4% more funds holding

Funds holding: 46 → 48 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

26% less capital invested

Capital invested by funds: $91.2M → $67M (-$24.2M)

Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
21
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACA
Avoro Capital Advisors
New York
+$1.46M
2
RI
RTW Investments
New York
+$1.44M
3
JGC
J. Goldman & Co
New York
+$1.11M
4
IG
ING Group
Netherlands
+$968K
5
ACP
Acuta Capital Partners
California
+$721K

Top Sellers

1
MHP
Manatuck Hill Partners
Connecticut
-$2.87M
2
PA
Perceptive Advisors
New York
-$2.48M
3
PVI
Pura Vida Investments
New York
-$1.44M
4
SSA
Schonfeld Strategic Advisors
New York
-$790K
5
1CM
1492 Capital Management
Wisconsin
-$382K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$128K +$148K +24 New
Deutsche Bank
27
Deutsche Bank
Germany
$120K +$37K +6 +35%
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$106K – – –
Millennium Management
29
Millennium Management
New York
$96K +$111K +18 New
RJFSA
30
Raymond James Financial Services Advisors
Florida
$93K +$24.7K +4 +29%
Wells Fargo
31
Wells Fargo
California
$84K +$67.8K +11 +220%
1CM
32
1492 Capital Management
Wisconsin
$79K -$382K -62 -81%
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$69K -$12.3K -2 -13%
CS
34
Credit Suisse
Switzerland
$59K +$67.8K +11 New
AIG
35
American International Group
New York
$53K +$6.17K +1 +11%
NFA
36
Nationwide Fund Advisors
Ohio
$45K – – –
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$23K +$24.7K +4 New
TRCT
38
Tower Research Capital (TRC)
New York
$20K +$24.7K +4 New
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$19K +$24.7K +4 New
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$15K – – –
Legal & General Group
41
Legal & General Group
United Kingdom
$12K – – –
LTFS
42
Ladenburg Thalmann Financial Services
Florida
$12K +$12.3K +2 New
UBS Group
43
UBS Group
Switzerland
$11K +$12.3K +2 New
Bank of America
44
Bank of America
North Carolina
$9K +$6.17K +1 +100%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$7.66K -$6.17K -1 -50%
AIP
46
Ameritas Investment Partners
Nebraska
$7K – – –
JP Morgan Chase
47
JP Morgan Chase
New York
$5K -$123K -20 -95%
AG
48
Advisor Group
Arizona
$3K – – –
Barclays
49
Barclays
United Kingdom
$3K – – –
TDC
50
Thompson Davis & Co
Virginia
$1K -$6.17K -1 Closed
1
2
3

VIVE Hedge Fund Activity: Q3 2017 in Review

48 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q3 2017, worth a combined $67M — down 26% from $91.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new VIVE positions and 7 closed out — a net gain of 3 holders — while 21 added to existing stakes and 7 trimmed.

The largest buyer was Avoro Capital Advisors, adding an estimated $1.46M. The largest seller was Manatuck Hill Partners, exiting entirely with an estimated $2.87M sold.

  • 48 institutional investors held VIVEVE MED INC (VIVE) as of Q3 2017, up from 46 in Q2 2017.
  • Funds reported $67M of VIVEVE MED INC stock for Q3 2017, down 26% quarter-over-quarter.
  • 10 funds opened new VIVEVE MED INC positions in Q3 2017 and 7 closed out, a net change of +3 holders.
  • The largest VIVEVE MED INC buyer in Q3 2017 was Avoro Capital Advisors, an estimated $1.46M added.
  • The largest VIVEVE MED INC seller in Q3 2017 was Manatuck Hill Partners, an estimated $2.87M sold.

Based on aggregated 13F filings for Q3 2017.